262 related articles for article (PubMed ID: 20467289)
1. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals.
van Sighem AI; Gras LA; Reiss P; Brinkman K; de Wolf F;
AIDS; 2010 Jun; 24(10):1527-35. PubMed ID: 20467289
[TBL] [Abstract][Full Text] [Related]
2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
Antiretroviral Therapy Cohort Collaboration
Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
[TBL] [Abstract][Full Text] [Related]
3. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
Helleberg M; May MT; Ingle SM; Dabis F; Reiss P; Fätkenheuer G; Costagliola D; d'Arminio A; Cavassini M; Smith C; Justice AC; Gill J; Sterne JA; Obel N
AIDS; 2015 Jan; 29(2):221-9. PubMed ID: 25426809
[TBL] [Abstract][Full Text] [Related]
4. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
[TBL] [Abstract][Full Text] [Related]
5. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy.
Fang CT; Chang YY; Hsu HM; Twu SJ; Chen KT; Lin CC; Huang LY; Chen MY; Hwang JS; Wang JD; Chuang CY
QJM; 2007 Feb; 100(2):97-105. PubMed ID: 17277317
[TBL] [Abstract][Full Text] [Related]
6. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
[TBL] [Abstract][Full Text] [Related]
7. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.
Losina E; Schackman BR; Sadownik SN; Gebo KA; Walensky RP; Chiosi JJ; Weinstein MC; Hicks PL; Aaronson WH; Moore RD; Paltiel AD; Freedberg KA
Clin Infect Dis; 2009 Nov; 49(10):1570-8. PubMed ID: 19845472
[TBL] [Abstract][Full Text] [Related]
8. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Lohse N; Hansen AB; Pedersen G; Kronborg G; Gerstoft J; Sørensen HT; Vaeth M; Obel N
Ann Intern Med; 2007 Jan; 146(2):87-95. PubMed ID: 17227932
[TBL] [Abstract][Full Text] [Related]
9. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.
May M; Gompels M; Delpech V; Porter K; Post F; Johnson M; Dunn D; Palfreeman A; Gilson R; Gazzard B; Hill T; Walsh J; Fisher M; Orkin C; Ainsworth J; Bansi L; Phillips A; Leen C; Nelson M; Anderson J; Sabin C
BMJ; 2011 Oct; 343():d6016. PubMed ID: 21990260
[TBL] [Abstract][Full Text] [Related]
10. Life expectancy after initiation of combination antiretroviral therapy in Thailand.
Teeraananchai S; Chaivooth S; Kerr SJ; Bhakeecheep S; Avihingsanon A; Teeraratkul A; Sirinirund P; Law MG; Ruxrungtham K
Antivir Ther; 2017; 22(5):393-402. PubMed ID: 28054931
[TBL] [Abstract][Full Text] [Related]
11. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care.
Marcus JL; Chao CR; Leyden WA; Xu L; Quesenberry CP; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
J Acquir Immune Defic Syndr; 2016 Sep; 73(1):39-46. PubMed ID: 27028501
[TBL] [Abstract][Full Text] [Related]
12. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
13. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.
Neilan AM; Karalius B; Patel K; Van Dyke RB; Abzug MJ; Agwu AL; Williams PL; Purswani M; Kacanek D; Oleske JM; Burchett SK; Wiznia A; Chernoff M; Seage GR; Ciaranello AL;
JAMA Pediatr; 2017 May; 171(5):450-460. PubMed ID: 28346597
[TBL] [Abstract][Full Text] [Related]
14. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
Lima VD; Hogg RS; Harrigan PR; Moore D; Yip B; Wood E; Montaner JS
AIDS; 2007 Mar; 21(6):685-92. PubMed ID: 17413689
[TBL] [Abstract][Full Text] [Related]
15. Sustained 10-year gain in adult life expectancy following antiretroviral therapy roll-out in rural Malawi: July 2005 to June 2014.
Price AJ; Glynn J; Chihana M; Kayuni N; Floyd S; Slaymaker E; Reniers G; Zaba B; McLean E; Kalobekamo F; Koole O; Nyirenda M; Crampin AC
Int J Epidemiol; 2017 Apr; 46(2):479-491. PubMed ID: 28338707
[TBL] [Abstract][Full Text] [Related]
16. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
[TBL] [Abstract][Full Text] [Related]
17. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals.
van Sighem A; Danner S; Ghani AC; Gras L; Anderson RM; de Wolf F;
J Acquir Immune Defic Syndr; 2005 Oct; 40(2):212-8. PubMed ID: 16186740
[TBL] [Abstract][Full Text] [Related]
19. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
Gueler A; Moser A; Calmy A; Günthard HF; Bernasconi E; Furrer H; Fux CA; Battegay M; Cavassini M; Vernazza P; Zwahlen M; Egger M;
AIDS; 2017 Jan; 31(3):427-436. PubMed ID: 27831953
[TBL] [Abstract][Full Text] [Related]
20. Mortality and progression to AIDS after starting highly active antiretroviral therapy.
van Sighem AI; van de Wiel MA; Ghani AC; Jambroes M; Reiss P; Gyssens IC; Brinkman K; Lange JM; de Wolf F;
AIDS; 2003 Oct; 17(15):2227-36. PubMed ID: 14523280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
